Natural products from mangrove actinomycetes DB Xu, WW Ye, Y Han, ZX Deng, K Hong Marine drugs 12 (5), 2590-2613, 2014 | 183 | 2014 |
Bioprospecting deep-sea actinobacteria for novel anti-infective natural products D Xu, L Han, C Li, Q Cao, D Zhu, NH Barrett, D Harmody, J Chen, H Zhu, ... Frontiers in microbiology 9, 787, 2018 | 37 | 2018 |
Nocardiopsistins AC: New angucyclines with anti-MRSA activity isolated from a marine sponge-derived Nocardiopsis sp. HB-J378 D Xu, KK Nepal, J Chen, D Harmody, H Zhu, PJ McCarthy, AE Wright, ... Synthetic and Systems Biotechnology 3 (4), 246-251, 2018 | 32 | 2018 |
Halichoblelide D, a New Elaiophylin Derivative with Potent Cytotoxic Activity from Mangrove-Derived Streptomyces sp. 219807 Y Han, E Tian, D Xu, M Ma, Z Deng, K Hong Molecules 21 (8), 970, 2016 | 24 | 2016 |
PreQ0 base, an unusual metabolite with anti-cancer activity from Streptomyces qinglanensis 172205 D Xu, M Ma, Y Liu, T Zhou, K Wang, Z Deng, K Hong Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2015 | 19 | 2015 |
Genotype-driven isolation of enterocin with novel bioactivities from mangrove-derived Streptomyces qinglanensis 172205 DB Xu, M Ma, ZX Deng, K Hong Applied microbiology and biotechnology 99, 5825-5832, 2015 | 13 | 2015 |
Identification of a novel lincomycin resistance mutation associated with activation of antibiotic production in Streptomyces coelicolor A3 (2) G Wang, M Izawa, X Yang, D Xu, Y Tanaka, K Ochi Antimicrobial agents and chemotherapy 61 (2), e02247-16, 2017 | 12 | 2017 |
Bioactive Molecules from Mangrove Streptomyces qinglanensis 172205 D Xu, E Tian, F Kong, K Hong Marine Drugs 18 (5), 255, 2020 | 11 | 2020 |
Uncovering Lasonolide A biosynthesis using genome-resolved metagenomics S Uppal, JL Metz, RKM Xavier, KK Nepal, D Xu, G Wang, JC Kwan Mbio 13 (5), e01524-22, 2022 | 8 | 2022 |
Inhibitory effect of a novel histone deacetylases inhibitor FK228 on human colon cancer HCT-116 cells in vitro and in vivo DB Xu, YL Wang, Y Yue, SC Wu, H Ding Zhonghua Zhong liu za zhi [Chinese Journal of Oncology] 35 (11), 814-818, 2013 | 5 | 2013 |
A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer. D Xu, Q Cao, L Wang, J Wang, B Xu, K Atwood, L Wei, Y Wu, GJ Smith, ... Molecular Cancer Therapeutics, 2022 | 4 | 2022 |
Brominated and sulfur-containing angucyclines derived from a single pathway: identification of nocardiopsistins D–F D Xu, J Metz, D Harmody, T Peterson, P Winder, EA Guzmán, R Russo, ... Organic Letters 24 (43), 7900-7904, 2022 | 3 | 2022 |
Ex Vivo Organoid Model of Adenovirus-Cre Mediated Gene Deletions in Mouse Urothelial Cells D Xu, L Wang, K Wieczorek, Y Wang, X Zhang, DW Goodrich, Q Li JoVE (Journal of Visualized Experiments), e63855, 2022 | 3 | 2022 |
Single-cell analyses of a novel mouse urothelial carcinoma model reveal a role of tumor-associated macrophages in response to anti-PD-1 therapy D Xu, L Wang, K Wieczorek, Y Zhang, Z Wang, J Wang, B Xu, PK Singh, ... Cancers 14 (10), 2511, 2022 | 2 | 2022 |
Genome Sequence of Streptomyces sp. Strain HB-N217, Isolated from the Marine Sponge Forcepia sp RKM Xavier, D Xu, PJ McCarthy, S Yang, G Wang Microbiology Resource Announcements 10 (8), 10.1128/mra. 01410-20, 2021 | 2 | 2021 |
MP14-12 MODELING IMMUNOTHERAPY RESISTANCE OF BLADDER CANCER IN IMMUNOCOMPETENT MICE D Xu, L Wang, K Wieczorek, B Xu, D Goodrich, Q Li The Journal of Urology 209 (Supplement 4), e187, 2023 | | 2023 |
MP06-09 SINGLE CELL ANALYSES OF MURINE UROTHELIAL CARCINOMA CELLS REVEAL A ROLE OF TUMOR-ASSOCIATED MACROPHAGES IN RESPONSE TO ANTI-PD1 THERAPY D Xu, L Wang, Y Zhang, Y Wang, X Zhang, Y Wu, G Smith, B Xu, P Singh, ... The Journal of Urology 207 (Supplement 5), e80, 2022 | | 2022 |
Abstract B13: A novel mouse model for small-cell carcinoma of bladder D Xu, Q Cao, L Wang, Y Wang, X Zhang, Y Wu, G Smith, B Xu, ... Cancer Research 80 (11_Supplement), B13-B13, 2020 | | 2020 |
MP01-10 A NOVEL MOUSE AND ORGANOID MODEL FOR SMALL CELL CARCINOMA OF BLADDER D Xu*, Q Cao, L Wang, Y Wang, Y Wu, X Zhang, G Smith, B Xu, ... The Journal of Urology 203 (Supplement 4), e5-e5, 2020 | | 2020 |
MP51-16 SPIRONOLACTONE, A NUCLEOTIDE EXCISION REPAIR INHIBITOR, POTENTIATES CYTOTOXIC EFFECT OF CISPLATIN IN BLADDER CANCER CELLS D Xu*, L Wang, Y Wu, G Smith, E Kauffman, J Mohler, D Goodrich, Q Li The Journal of Urology 201 (Supplement 4), e729-e730, 2019 | | 2019 |